These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 7655018

  • 1. BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes.
    Oudejans JJ, van den Brule AJ, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JM, Meijer CJ.
    Blood; 1995 Sep 01; 86(5):1893-902. PubMed ID: 7655018
    [Abstract] [Full Text] [Related]

  • 2. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK, Tao Q, Srivastava G, Ho FC.
    Int J Cancer; 1996 Nov 04; 68(3):285-90. PubMed ID: 8903467
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N, Sarker AB, Tonoyama Y, Yoshino T, Hayashi K, Takahashi K, Akagi T.
    Cancer; 1996 Jun 01; 77(11):2339-47. PubMed ID: 8635105
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P, Meggetto F, Chittal S, Bibeau F, Arnaud J, Rubin B, Delsol G.
    Lab Invest; 1993 Oct 01; 69(4):483-90. PubMed ID: 8231115
    [Abstract] [Full Text] [Related]

  • 5. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
    Jiwa NM, Oudejans JJ, Bai MC, Van den Brule AJ, Horstman A, Vos W, Van der Valk P, Kluin PM, Walboomers JM, Meijer CJ.
    Histopathology; 1995 Jun 01; 26(6):547-53. PubMed ID: 7665145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT, Fernandes BJ, Mock D.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 01; 92(2):184-93. PubMed ID: 11505266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus BHRF1 gene but not the cellular protooncogene bcl-2 is expressed in ataxia-telangiectasia lymphoblastoid lines.
    Becker Y, Tabor E, Asher Y.
    Virus Genes; 1991 Jan 01; 5(1):33-45. PubMed ID: 1850186
    [Abstract] [Full Text] [Related]

  • 11. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
    Oudejans JJ, Jiwa M, van den Brule AJ, Grässer FA, Horstman A, Vos W, Kluin PM, van der Valk P, Walboomers JM, Meijer CJ.
    Am J Pathol; 1995 Oct 01; 147(4):923-33. PubMed ID: 7573368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characteristics of Epstein-Barr virus isolated from the malignant lymphomas in Korea.
    Kim I, Park ER, Park SH, Lin Z, Kim YS.
    J Med Virol; 2002 May 01; 67(1):59-66. PubMed ID: 11920819
    [Abstract] [Full Text] [Related]

  • 14. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.
    Murray PG, Swinnen LJ, Constandinou CM, Pyle JM, Carr TJ, Hardwick JM, Ambinder RF.
    Blood; 1996 Jan 15; 87(2):706-11. PubMed ID: 8555494
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K, Suzumiya J, Tasiro K, Mukai Y, Tanaka T, Kato A, Kikuchi M.
    Am J Hematol; 1996 May 15; 52(1):21-8. PubMed ID: 8638607
    [Abstract] [Full Text] [Related]

  • 16. Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.
    Brink AA, Vervoort MB, Middeldorp JM, Meijer CJ, van den Brule AJ.
    J Clin Microbiol; 1998 Nov 15; 36(11):3164-9. PubMed ID: 9774558
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H.
    J Pathol; 1995 Mar 15; 175(3):263-71. PubMed ID: 7745495
    [Abstract] [Full Text] [Related]

  • 18. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, Reyes E, Gredler E, Krugmann J, Fend F, Quintanilla-Martinez L.
    Hum Pathol; 1999 Jul 15; 30(7):781-7. PubMed ID: 10414496
    [Abstract] [Full Text] [Related]

  • 19. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, Scott RS, Johannsen EC, Kenney SC.
    PLoS Pathog; 2020 Jun 15; 16(6):e1008590. PubMed ID: 32542010
    [Abstract] [Full Text] [Related]

  • 20. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site.
    de Bruin PC, Jiwa M, Oudejans JJ, van der Valk P, van Heerde P, Sabourin JC, Csanaky G, Gaulard P, Noorduyn AL, Willemze R.
    Blood; 1994 Mar 15; 83(6):1612-8. PubMed ID: 8123852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.